Answers are grounded in this paper and cite their sources.
Chronic myeloid leukemia (CML) is driven by the BCR-ABL fusion oncoprotein, a constitutively active tyrosine kinase whose inhibition by tyrosine kinase inhibitors (TKIs) transformed disease management. However, kinase-domain mutations, persistent leukemic stem cells (LSCs), and kinase-independent survival mechanisms still limit durable treatment-free remission. Increasing evidence indicates that BCR-ABL is regulated not only by kinase activity but also by post-translational modifications (PTMs) determining protein stability, turnover, interactions, and degradation. In this review, we examine how ubiquitination, SUMOylation, NEDDylation, phosphorylation, and acetylation-associated chaperone regulation control BCR-ABL proteostasis. Ubiquitin-dependent regulation involves opposing activities of E3 ligases and deubiquitinating enzymes, while TRIM28-mediated SUMOylation and RAPSYN-mediated NEDDylation stabilize BCR-ABL by limiting p62-dependent autophagic and c-CBL-mediated degradation, respectively. Crosstalk among these pathways suggests an integrated PTM network governs BCR-ABL fate rather than independent modifications. These mechanisms may impact persistent CML populations, though direct evidence linking specific PTMs to LSC maintenance remains limited. Therapeutically, manipulating PTM-dependent proteostasis via deubiquitinase inhibition, SUMO/NEDD8 modulation, chaperone disruption, and targeted protein degradation can complement conventional kinase inhibition. Notably, BCR-ABL-directed proteolysis-targeting chimeras (PROTACs) demonstrate the feasibility of eliminating the fusion protein rather than solely suppressing its catalytic activity. Ultimately, PTM-dependent proteostasis represents a critical regulatory dimension and therapeutic vulnerability in CML. Defining the spatial, temporal, and disease-specific PTM landscape of BCR-ABL is essential to determine if selective stability manipulation can overcome resistance and deepen therapeutic responses.
No takes yet. Share an insight, caveat, or question.
Shammas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: